Contemporary management of the pseudotumor cerebri syndrome

References

• Digre KB, BruceBB, McDermott MP, et al. Quality of life in idiopathic intracranial hypertension at diagnosis: IIH treatment trial results. Neurology. 2015;84:2449–2456.
   PubMed Web of Science ®Google Scholar
• Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology. 2002;58:1551–1553.
   PubMed Web of Science ®Google Scholar
• Yri HM, Rönnbäck C, Wegener M, et al. The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol. 2014;21:1458–1464.
   PubMed Web of Science ®Google Scholar
• Fisayo A, Bruce BB, Newman NJ, et al. Overdiagnosis of idiopathic intracranial hypertension. Neurology. 2016;86:341–350.
   PubMedGoogle Scholar
• Friedman DI, Liu G, Digre KB. Diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–1165.
   PubMed Web of Science ®Google Scholar
• Digre KB, Nakamoto BK, Warner JE, et al. A comparison of idiopathic intracranial hypertension with and without papilledema. Headache. 2009;49:185–193.
   PubMed Web of Science ®Google Scholar
• Brosh K, Strassman I. Unilateral papilledema in pseudotumor cerebri. Semin Ophthalmol. 2013;28:242–243.
   PubMed Web of Science ®Google Scholar
• Bidot S, Bruce BB, Saindane AM, et al. Asymmetric papilledema in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35:31–36.
   PubMed Web of Science ®Google Scholar
• Mallery RM, Rehmani OF, Woo JH, et al. Utility of magnetic resonance imaging features for improving the diagnosis of idiopathic intracranial hypertension without papilledema. J Neuroophthalmol. 2019;39:299–307.
   Google Scholar
• Kohli AA, Vossough A, Mallery RM, et al. Magnetic resonance imaging findings in pediatric pseudotumor cerebri syndrome. Pediatr Neurol. 2019. (Epub ahead of print, PMID 31303369).
   PubMedGoogle Scholar
• Headache Classification Committee of the International Headache Society. The international classification of headache disorders; Vol. 38. 3rd ed. Cephalalgia; 1028. p. 100–101.
   Google Scholar
• Friedman DI, Gordon LK, Egan RA, et al. Doxycycline and intracranial hypertension. Neurology. 2004;22:2297–2299.
   Google Scholar
• Mollan SP, Ball AK, Sinclair AJ, et al. Idiopathic intracranial hypertension associated with iron deficiency anaemia: a lesson for management. Eur Neurol. 2009;62:105–108.
   PubMed Web of Science ®Google Scholar
• Hoffmann J, Mollan SP, Paemeleire K, et al. European headache federation guideline on idiopathic intracranial hypertension. J Headache Pain. 2018;19:93.
   PubMed Web of Science ®Google Scholar
• Albrecht P, Blasberg C, Ringelstein M, et al. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J Neurol. 2017;264:137–180.
   Web of Science ®Google Scholar
• Costello F, Malmqvist L, Hamann S. The role of optical coherence tomography in differentiating optic disc drusen from optic disc edema. Asia Pac J Ophthalmol. 2018;7:271–279.
   PubMed Web of Science ®Google Scholar
• Auinger P, Durbin P, Feldon S, et al.; OCT Sub-Study Committee for NORDIC Idiopathic Intracranial Hypertension Study Group. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Invest Ophthalmol Vis Sci. 2014;55:8173–8179.
   PubMed Web of Science ®Google Scholar
• Kanner LA, Klein J, Gaffar M, et al. New-onset isolated asymptomatic papilledema in two patients treated with recombinant growth hormone. Clin Pediatr. 2018;57:471–474.
   PubMed Web of Science ®Google Scholar
• Friedman DI, McDermott MP, Kieburtz K, et al.; the NORDIC IIHTT Study Group. The idiopathic intracranial hypertension treatment trial: design considerations and methods. J Neuro-Ophthalmol. 2014;34:107–117.
   PubMed Web of Science ®Google Scholar
• Wall M, McDermott MP, Kieburtz KD. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss. JAMA Neurol. 2014;13(16):1641–1651.
   Google Scholar
• Cello K, Keltner JL, Johnson CA, et al.; the NORDIC Idiopathic Intracranial Hypertension Study Group. Factors affecting visual field outcomes in the idiopathic intracranial hypertension treatment trial. J Neuroophthalmol. 2016;36:6–12.
   PubMed Web of Science ®Google Scholar
• Ney JJ, Volpe NJ, Liu GT, et al. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology. 2009;116:1808–1813.
   PubMed Web of Science ®Google Scholar
• Lomelino C, McKenna R. Carbonic anhydrase inhibitor: a review on the progress of patent literature (2011–2016). Expert Opin Ther Pat. 2016;26:947–956.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Acetazolamide for the treatment of idiopathic intracranial hypertension. Exp Rev Neurother. 2015;15:851–856.
   PubMed Web of Science ®Google Scholar
• Kister SJ. Carbonic anhydrase inhibition. VI. The effect of acetazolamide on cerebrospinal fluid flow. J Pharm Exp Ther. 1956;117:402–405.
   PubMed Web of Science ®Google Scholar
• Dominelli PB, McNeil CJ, Vermeulen TD, et al. Effect of acetazolamide and methazolamide on diaphragm and dorsiflexor fatigue: a randomized controlled trial. J Appl Physiol. 1985;2018(125):770–779.
   Google Scholar
• Gücer G, Viernstein L. Long-term intracranial pressure recording in the management of pseudotumor cerebri. J Neurosurg. 1978;49:256–263.
   PubMed Web of Science ®Google Scholar
• Lubow M, Kuhr L. Pseudotumor cerebri: comments on practical management. In: Glaser JS, Smith JL, editors. Neuro-ophthalmology; Vol. IX. St. Louis, MO, CV Mosby; 1976. p. 199–206.
   Google Scholar
• Frisén L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982;45(1):13–18.
   PubMed Web of Science ®Google Scholar
• Wall M, Thurtell MG, NORDIC Idiopathic Intracranial Hypertension Study Group. Optic disc haemorrhages at baseline as a risk factor of poor outcome in the idiopathic intracranial hypertension treatment trial. Br J Ophthalmol. 2017;101:1256–1260.
   PubMed Web of Science ®Google Scholar
• Wall M, Faraldeau J, Fletcher WA, et al. Risk factors for poor visual outcome in patents with idiopathic intracranial hypertension. Neurology. 2015;85:799–805.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Thurtell MJ, Longmuir RA, et al. Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci. 2015;56:3850–3859.
   PubMed Web of Science ®Google Scholar
• Ten Hove MW, Friedman DI, Patel AD, et al. Safety and tolerability of acetazolamide in the idiopathic intracranial hypertension treatment trial. J Neuroophthalmol. 2016;36:13–19.
   PubMed Web of Science ®Google Scholar
• Falardeau J, Lobb BM, Golden S, et al. The use of acetazolamide during pregnancy in intracranial hypertension patients. J Neuroophthalmol. 2013;33:9–12.
   PubMed Web of Science ®Google Scholar
• Celebisoy N, Gökçay F, Sirin H, et al. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116:322–327.
   PubMed Web of Science ®Google Scholar
• Schoeman JF. Childhood pseudotumor cerebri: a clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994;9:130–134.
   PubMed Web of Science ®Google Scholar
• Kalhe KT, Walcott BP, Staley KJ. Resolution of headache and papilledema in idiopathic intracranial hypertension associate with inhibition of Na+-K+-2CL- cotransport. J Child Neurol. 2011;26:205–208.
   PubMed Web of Science ®Google Scholar
• Friedman DI, Streeten DHP. Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis. Neurology. 1998;50:1099–1104.
   PubMed Web of Science ®Google Scholar
• Platt D, Griggs RC. Use of acetazolamide in sulfonamide-allergic patients with neurologic channelopathies. Arch Neurol. 2012;69:527–529.
   PubMedGoogle Scholar
• Shah TJ, Moshirfar M, Hoopes PC Sr. “Doctor, I have a sulfa allergy”: clarifying the myths of cross-reactivity. Ophthalmol Ther. 2018;7:211–215.
   PubMed Web of Science ®Google Scholar
• Strom BL, Schinnar R, Apter AJ. Absence of cross reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med. 2003;349:1628–1635.
   PubMed Web of Science ®Google Scholar
• Lee AG, Anderson R, Kardon RH, et al. Presumed “sulfa allergy” in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality? Am J Ophthalmol. 2004;138:114–118.
   PubMed Web of Science ®Google Scholar
• Panagopoulos GN, Deftereos SN, Tagaris GA, et al. Octreotide: a therapeutic option for idiopathic intracranial hypertension. Neurol Neurophysiol Neurosci. 2007 July 10;1.
   Google Scholar
• House PM, Stodieck SR. Octreotide: The IIH therapy beyond weight loss, carbonic anhydrase inhibitors, lumbar punctures and surgical/interventional treatments. Clin Neurol Neurosurg. 2016;150:181–184.
   PubMed Web of Science ®Google Scholar
• Kidron D, Pomeranz S. Malignant pseudotumor cerebri. Report of 2 cases. J Neurosurg. 1989;71:443–445.
   PubMed Web of Science ®Google Scholar
• Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol. 1994;118:88–96.
   PubMed Web of Science ®Google Scholar
• Kwon YJ, Allen JL, Liu GT, et al. Presumed pseudotumor cerebri syndrome after withdrawal of inhaled corticosteroids. Pediatr. 2016 June;137(6).
   Web of Science ®Google Scholar
• Friedman DI, Quiros PS, Mejico LJ, et al. Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache. 2017;57:1195–1205.
   PubMed Web of Science ®Google Scholar
• Friedman DI. Headaches in idiopathic intracranial hypertension. J Neuroophthalmol. 2019;39:82–93.
   PubMed Web of Science ®Google Scholar
• Sugita U, Iijima S, Teshima Y, et al. Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome. Electroencephalogr Clin Neurophysiol. 1985;60:214–219.
   PubMedGoogle Scholar
• Wall M, Purvin V. Idiopathic intracranial hypertension in men and the relationship to sleep apnea. Neurology. 2009;72:300–301.
   PubMed Web of Science ®Google Scholar
• Thurtell MJ, Trotti LM, Bixler EO, et al. Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with population matched data. J Neurol. 2013;260:1748–1751.
   PubMed Web of Science ®Google Scholar
• Avisar I, Gaton DD, Dania H, et al. The prevalence of polycystic ovary syndrome in women with idiopathic intracranial hypertension. Scientifica (Cairo). 2012;2012:708042.
   PubMedGoogle Scholar
• Glueck CJ, Golnik KC, Aregawi D, et al. Changes in weight, papilledema, headache, visual field and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia. Trans Res. 2006;148:215–222.
   Google Scholar
• Fishman RA. Formation of the CSF in cerebrospinal fluid in diseases of the nervous system, second edition. Fishman RA, ed. Philadelphia: W.B Saunders Company; 1992. p. 24–25.
   Google Scholar
• Singleton J, Dagan A, Edlow JA, et al. Real-time optic nerve sheath diameter reduction measured with bedside ultrasound after therapeutic lumbar puncture in a patient with idiopathic intracranial hypertension. Am J Emerg Med. 2015;33:860.e5–7.
   PubMed Web of Science ®Google Scholar
• Horev A, Hallevy H, Plakht Y, et al. Changes in cerebral venous sinuses diameter after lumbar puncture in idiopathic intracranial hypertension: A prospective MRI study. J Neuroimaging. 2013;23:375–378.
   PubMed Web of Science ®Google Scholar
• Buell TJ, Raper DMS, Pomeraniec IJ, et al. Transient resolution of venous sinus stenosis after high-volume lumbar puncture in a patient with idiopathic intracranial hypertension. J Neurosurgy. 2018;129:153–156.
   PubMed Web of Science ®Google Scholar
• Chan W, Neufeld A, Maxner C, et al. Irreversibility of transverse sinus stenosis and optic nerve edema post-lumbar puncture in idiopathic intracranial hypertension. Can J Ophthalmol. 2019;54:e57–59.
   PubMed Web of Science ®Google Scholar
• Gates P, McNeill P. A possible role for temporary lumbar drainage in the management of idiopathic intracranial hypertension. Neuroophthalmology. 2016;40:277–280.
   PubMed Web of Science ®Google Scholar
• Jiramongkolchai K, Buckley EG, Bhatti MT, et al. Temporary lumbar drain as a treatment for pediatric fulminant idiopathic intracranial hypertension. J Neuroophthalmol. 2017;37:126–132.
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Fletcher W. Obesity and weight loss in idiopathic intracranial hypertension: A narrative review. J Neuroophthalmol. 2017;37:197–205.
   PubMed Web of Science ®Google Scholar
• Newborg B. Pseudotumor cerebri treated with rice reduction diet. Arch Int Med. 1974;133:802–807.
   PubMed Web of Science ®Google Scholar
• Kupersmith MJ, Gamell L, Turbin R, et al. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology. 1998;50:1094–1098.
   PubMed Web of Science ®Google Scholar
• Johnson LN, Krohel GB, Madsen RW, et al. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105:2313–2317.
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341:c2701.
   PubMed Web of Science ®Google Scholar
• Ottridge R, Mollan SR, Botfield H, et al. Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol. BMJ Open. 2017;7:3017426.
   Google Scholar
• Ko MW, Chang SC, Ridha MA, et al. Weight gain and recurrence in idiopathic intracranial hypertension: A case control study. Neurology. 2011;76:1563–1567.
   Web of Science ®Google Scholar
• McGeeney B, Friedman DI. Pseudotumor cerebri pathophysiology. Headache. 2014;54(3):445–458.
   PubMed Web of Science ®Google Scholar
• Fraser JA, Bruce BB, Rucker J, et al. Risk factors for idiopathic intracranial hypertension in men: a case-control study. J Neurol Sci. 2010;290:86–89.
   PubMed Web of Science ®Google Scholar
• Breznikar B, Dinevski D. Bariatric surgery for morbid obesity: pre-operative assessment, surgical techniques and post-operative monitoring. J Int Med Res. 2009;37:1632–1645.
   PubMed Web of Science ®Google Scholar
• Handley JD, Baruah BP, Williams DM, et al. Bariatric surgery as a treatment for intracranial hypertension: a systematic review. Surg Obes Relat Dis. 2015;11:1396–1403.
   PubMed Web of Science ®Google Scholar
• Manfield JH, Yu K-H, Efthimiou EE, et al. Bariatric surgery or non-surgical weight loss for idiopathic intracranial hypertension? A systematic review and comparison of meta-analyses. Obes Surg. 2017;27:513–521.
   PubMed Web of Science ®Google Scholar
• Ball AK, Howman A, Wheatley K, et al. A randomized controlled trial of treatment for idiopathic intracranial hypertension. J Neurol. 2011;258:874–881.
   PubMed Web of Science ®Google Scholar
• National Institute of Diabetes and Digestive and Kidney Diseases. Bariatric surgery. [cited 2019 September 15]. Available from: https://www.niddk.nih.gov/health-information/weight-management/bariatric-surgery
   Google Scholar
• Kalyvas AV, Highes M, Koutsarnakis C, et al. Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature. Acta Neurochir (Wien). 2017;159:33–49.
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Woodworth G, Thomas G, et al. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and analysis of long-term outcomes. J Neurosurg. 2004;101:627–632.
   PubMed Web of Science ®Google Scholar
• Curry WT, Butler WE, Barker FG 2nd. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States,1988–2002. Neurosurgery. 2005;57:97–108.
   PubMed Web of Science ®Google Scholar
• Surgical Idiopathic Intracranial Hypertension Treatment Trial (SIGHT). [cited 2019 September 15]. Available from: https://clinicaltrials.gov/ct2/show/NCT03501966
   Google Scholar
• Fok A, Chandra RV, Gutman M, et al. Posterior reversible encephalopathy syndrome and subarachnoid hemorrhage after lumboperitoneal shunt for fulminant idiopathic intracranial hypertension. J Neuroophthalmol. 2016;36:164–166.
   PubMed Web of Science ®Google Scholar
• Rizzo JL, Lam KV, Wall M, et al. Perimetry, retinal nerve fiber layer thickness and papilledema grade after cerebrospinal fluid shunting in patients with idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35:22–25.
   PubMed Web of Science ®Google Scholar
• Menger RP, Connor DE Jr, Thakur JD, et al. A comparison of lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension: an analysis of economic impact and complications using the nationwide inpatient sample. Neurosurg Focus. 2014;37:E4.
   PubMed Web of Science ®Google Scholar
• Azad TD, Zhang T, Varshneya A, et al. Lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension demonstrate comparable failure and complication rates. Neurosurgery. 2019 April 1. (Epub ahead of print). PMID 30937428.
   Google Scholar
• Dandy WE. Intracranial pressure without brain tumor. Diagnosis and treatment. Ann Surg. 1937;106:492–513.
   PubMedGoogle Scholar
• Farb RI, Vaneck I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003;13:1418–1424.
   Web of Science ®Google Scholar
• Ahmed RM, Wilkinson M, Parker GD. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and model predictions. AJNR Am J Neuroradiol. 2011;32:1408–1414.
   PubMed Web of Science ®Google Scholar
• Teleb MS, Cziep ME, Lazzaro MA, et al. Idiopathic intracranial hypertension: A systematic analysis of transverse sinus stenting. Interv Neurol. 2013;2:132–143.
   PubMedGoogle Scholar
• McDougall CM, Ban VS, Beecher J, et al. Fifty shade of gradients: does the pressure gradient in venous sinus stenting for idiopathic intracranial hypertension matter? A systemic review. J Neurosurgy. 2018;1:1–7.
   Google Scholar
• Guo XB, Wei S, Guan S. Intracranial venous pressures manometry for patients with idiopathic intracranial hypertension: under awake setting or general anesthesia. Front Neurol. 2019;10:751.
   PubMed Web of Science ®Google Scholar
• Raper DMS, Buell TJ, Chen CJ, et al. Intracranial venous pressures under conscious sedation. J Neurointerv Surg. 2017;9:986–989.
   PubMed Web of Science ®Google Scholar
• Kumpe DA, Seinfeld J, Huang X, et al. Dural sinus stenting for idiopathic intracranial hypertension: factors associated with hemodynamic failure and management with extended stenting. J Neurointerv Surg. 2017;9:867–874.
   PubMed Web of Science ®Google Scholar
• Dinkin MJ, Patsalides A. Venous sinus stenting in idiopathic intracranial hypertension: Results of a prospective trial. J Neuroophthalmol. 2017;37:113–121.
   PubMed Web of Science ®Google Scholar
• Patsalides A, Oliveira C, Wilcox J, et al. Venous sinus stenting lowers the intracranial pressure in patients with idiopathic intracranial hypertension. J Neurointerv Surg. 2019;11:175–178.
   PubMed Web of Science ®Google Scholar
• El Mekabaty A, Obuchowski NA, Luciano MG, et al. Predictors for venous sinus stent retreatment in patients with idiopathic intracranial hypertension. J Neurointerv Surgy. 2017;9:1228–1232.
   PubMed Web of Science ®Google Scholar
• Saber H, Lewis W, Sadeghi M, et al. Stent survival and stent-adjacent stenosis rates following venous sinus stenting for idiopathic intracranial hypertension: A systematic review and meta-analysis. Interv Neurol. 2018;7:490–500.
   PubMed Web of Science ®Google Scholar
• Ravid S, Shahar E, Schif A, et al. Visual outcome and recurrence rate in children with idiopathic intracranial hypertension. J Child Neurol. 2015;30:1448–1452.
   PubMed Web of Science ®Google Scholar
• Winters HS, Parker G, Halmagyi GM, et al. Delayed relapse in pseudotumor cerebri due to new stenosis after transverse venous sinus stenting. J Neurointerv Surg. 2016.
   PubMed Web of Science ®Google Scholar